Sovaldi won eu approval

Report Medical Device News May 2, 2014 · The drug sofosbuvir (trade name: Sovaldi) has been approved since January 2014 for the treatment of hepatitis C infection in adults. [3] [6] Common side effects include fatigue, headache, nausea, and trouble sleeping

2024-03-29
    Montelukast on bacterial sinusitis
  1. On November 22, the FDA approved Olysio (simeprevir)
  2. 4 Special warnings and precautions for use
  3. S
  4. What benefits of Sovaldi have been shown in studies? Sovaldi has been
  5. Food and Drug Administration (
  6. Sovaldi is also close to winning European Commission (EC) approval
  7. 22, the FDA approved Olysio (simeprevir)
  8. Generic Name: sofosbuvir